Ciprofloxacin-associated seizures in a patient with underlying thyrotoxicosis: Case report and literature review

International Journal of Clinical Pharmacology and Therapeutics

Volumn 47, Issue 5, 2009, Pages 303-310

  Agbaht, Kemala ^a   Bitik, B ^b   Piskinpasa, S ^b   Bayraktar, M ^b   Topeli, A ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Ciprofloxacin; Risk factors; Seizure; Thyrotoxicosis

Indexed keywords

C REACTIVE PROTEIN; CIPROFLOXACIN; CREATINE KINASE; CREATININE; LACTATE DEHYDROGENASE; MYOGLOBIN; PIPERACILLIN PLUS TAZOBACTAM; PROCALCITONIN; PROPRANOLOL; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE; TRIIODOTHYRONINE DERIVATIVE; UREA; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD GAS ANALYSIS; CASE REPORT; CLINICAL FEATURE; CONFUSION; CONSCIOUSNESS DISORDER; CONVULSION; CREATININE BLOOD LEVEL; DISORIENTATION; DYSURIA; ELECTROENCEPHALOGRAPHY; ELECTROLYTE DISTURBANCE; FEMALE; FEVER; FREE THYROXINE INDEX; GRAND MAL SEIZURE; HABIT; HEADACHE; HEMODIALYSIS; HUMAN; HYPERSALIVATION; HYPOTENSION; LABORATORY TEST; LETHARGY; LEUKOCYTOSIS; MENINGITIS; METABOLIC ACIDOSIS; MYOPATHY; POSTPARTUM THYROIDITIS; RISK FACTOR; SEPSIS; SIDE EFFECT; SINUSITIS; TACHYCARDIA; TACHYPNEA; THYROTOXICOSIS; TONGUE BITING; TONIC CLONIC SEIZURE; UNCONSCIOUSNESS; UREA BLOOD LEVEL; URINALYSIS; URINARY TRACT INFECTION; URINE INCONTINENCE; CHEMICALLY INDUCED DISORDER; REVIEW; SEIZURE;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; RISK FACTORS; SEIZURES; SINUSITIS; THYROTOXICOSIS; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 67649411865     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP47303     Document Type: Article

References (34)

1. Adler D, Voide C et al. SIADH consecutive to ciprofloxacin intake. Eur J Intern Med. 2004; 15: 463-464.
2. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000; 21: 1581-1589.
3. Allon M, Lopez EJ et al. Acute renal failure due to ciprofloxacin. Arch Intern Med. 1990; 150: 2187-2189.
4. Bailey JR, Trott SA et al. Ciprofloxacin-induced acute interstitial nephritis. Am J Nephrol. 1992; 12: 271-273.
5. Ball P, Tillotson G. Tolerability of fluoroquinolone antibiotics. Past, present and future. Drug Saf. 1995; 13: 343-358.
6. Bauer J. Catamenial epilepsy and menopause. Epilepsia. 2001; 42: 572.
7. Castilla-Guearra L, del Carmen Fernandez-Moreno M et al. Electrolytes disturbances and seizures. Epilepsia. 2006; 47: 1990-1998.
8. Davis R, Markham A et al. Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability. Drugs. 1996; 51: 1019-1074.
9. De Sarro A, De Sarro G. Adverse reactions to fluoroquinolones. an overview on mechanistic aspects. Curr Med Chem. 2001; 8: 371-384.
10. Fink MP, Snydman DR et al. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Antimicrob Agents Chemother. 1994; 38: 547-557.
11. Halliwell RF, Davey PG et al. Antagonism of GABAA receptors by 4-quinolones. JAntimicrobChemother. 1993; 31: 457-462.
12. Hori S, Kizu J et al. Effects of antiinflammatory drugs on convulsant activity of quinolones: a comparative study of drug interaction between quinolones and antiinflammatory drugs. J Infect Chemother. 2003; 9: 314-320.
13. Jick SS, Jick H et al. A follow-up safety study of ciprofloxacin users. Pharmacotherapy. 1993; 13: 461-464.
14. Karakoc E, Erdem S et al. Encephalopathy due to carnitine deficiency in an adult patient with gluten enteropathy. Clin Neurol Neurosurg. 2006; 108: 794-797.
15. Karki SD, Bentley DW et al. Seizure with ciprofloxacin and theophylline combined therapy. Dicp. 1990; 24: 595-596.
16. Kisa C, Yildirim SG et al. Prolonged electroconvulsive therapy seizure in a patient taking ciprofloxacin. J Ect. 2005; 21: 43-44.
17. Kushner JM, Peckman HJ et al. Seizures associated with fluoroquinolones. Ann Pharmacother. 2001; 35: 1194-1198.
18. Mandell LA, Ball P et al. Antimicrobial safety and tolerability: differences and dilemmas. Clin Infect Dis. 2001; 32 (Suppl. 1): S72-S79.
19. Onur O, Guneysel O et al. Importance of muscle mass in acute tubular necrosis due to rhabdomyolisis: Case report. Marmara Med J. 2006; 19: 30-32.
20. Orr CF, Rowe DB. Eardrop attacks: seizures triggered by ciprofloxacin eardrops. Med J Aust. 2003; 178: 343.
21. Owens RC, Ambrose PG. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis. 2005; 41: S144-S157.
22. Pea F, Poz D et al. Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? ATDM-based retrospective perspective. J Antimicrob Chemother. 2006; 58: 380-386.
23. Pea F, Viale P. The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients? Clin Infect Dis. 2006; 42: 1764-1771.
24. Rubinstein E, Segev S. Drug interactions of ciprofloxacin with other nonantibiotic agents. Am J Med. 1987; 82: 119-123.
25. Schmuck G, Schurmann A et al. Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model. Antimicrob Agents Chemother. 1998; 42: 1831-1836.
26. Schwartz MT, Calvert JF. Potential neurologic toxicity related to ciprofloxacin. Dicp. 1990; 24: 138-140.
27. Segev S, Rehavi M et al. Quinolones, theophylline, and diclofenac interactions with the γ-aminobutyric acid receptor. Antimicrob Agents Chemother. 1988; 32: 1624-1626.
28. Semel JD, Allen N. Seizures in patients simultaneously receiving theophylline and imipenem or ciprofloxacin or metronidazole. South Med J. 1991; 84: 465-468.
29. Shakeri-Nejad K, Stahlmann R. Drug interactions during therapy with three major groups of antimicrobial agents. Exp Opin Pharmacother. 2006; 7: 639-651.
30. Slavich IL, Gleffe RF et al. Grand mal epileptic seizures during ciprofloxacin therapy. JAMA. 1989; 261: 558-559.
31. Spivey JM, Laughlin PH et al. Theophylline toxicity secondary to ciprofloxacin administration. Ann Emerg Med. 1991; 20: 1131-1134.
32. Tattevin P, Messiaen T et al. Confusion and general seizures following ciprofloxacin administration Nephrol Dial Transplant. 1998; 13: 2712-2713.
33. Tonner DR, Schlechte JA. Neurologic complications of thyroid and parathyroid disease. Med Clin North Am. 1993; 77: 251-263.
34. Zhanel GG, Ennis K et al. A critical review of the fluoroquinolones: focus on respiratory infections. Drugs. 2002; 62: 13-59.I